Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey

被引:27
|
作者
Zanichelli, Andrea [1 ]
Magerl, Markus [2 ]
Longhurst, Hilary J. [3 ,10 ]
Aberer, Werner [4 ]
Caballero, Teresa [5 ]
Bouillet, Laurence [6 ]
Bygum, Anette [7 ]
Grumach, Anete S. [8 ]
Botha, Jaco [9 ]
Andresen, Irmgard [9 ]
Maurer, Marcus [2 ]
机构
[1] Univ Milan, ASST Fatebenefratelli Sacco, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy
[2] Charite Univ Med Berlin, Allergie Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany
[3] Barts Hlth NHS Trust, Dept Immunol, London, England
[4] Med Univ Graz, Dept Dermatol & Venereol, Graz, Austria
[5] Hosp La Paz Inst Hlth Res IdiPaz, Biomed Res Network Rare Dis CIBERER, Dept Allergy, U754, Madrid, Spain
[6] Grenoble Univ Hosp, Natl Reference Ctr Angioedema, Internal Med Dept, Grenoble, France
[7] Odense Univ Hosp, Dept Dermatol & Allergy Ctr, Odense, Denmark
[8] Fac Med ABC, Sao Paulo, Brazil
[9] Shire, Zug, Switzerland
[10] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England
来源
关键词
Hereditary angioedema; HAE; C1-INH-HAE; Diagnosis; Delay in diagnosis; BURDEN;
D O I
10.1186/s13601-018-0229-4
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The objective of this analysis was to evaluate the change over time in age at first symptoms, age at diagnosis, and delay in diagnosis using data from the Icatibant Outcome Survey (IOS). Patients with a diagnosis of C1-INH-HAE who were born before the year 1990 and who were diagnosed before they reached 25 years of age were included in the analysis. Both age at diagnosis and delay in diagnosis of C1-INH-HAE appear to decline with later decade of birth, despite wide variation across the countries assessed, suggesting that improved disease awareness causes increased rates of earlier diagnosis over time. Our findings demonstrate that some patients are still experiencing long delays to diagnosis, indicating an ongoing need for improved disease awareness.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
    Maurer, M.
    Bork, K.
    Martinez-Saguer, I.
    Aygoeren-Puersuen, E.
    Botha, J.
    Andresen, I.
    Magerl, M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (01) : 163 - 169
  • [22] The Icatibant Outcome Survey: experience of hereditary angioedema management from four European countries
    Caballero, T.
    Aberer, W.
    Longhurst, H.
    Maurer, M.
    Zanichelli, A.
    Fabien, V
    Bouillet, L.
    [J]. ALLERGY, 2014, 69 : 54 - 54
  • [23] The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries
    Caballero, T.
    Aberer, W.
    Longhurst, H. J.
    Maurer, M.
    Zanichelli, A.
    Perrin, A.
    Bouillet, L.
    Andresen, I.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (07) : 1214 - 1222
  • [24] Gender Analysis of Icatibant-Treatment Outcomes of Acute Angioedema Attacks in Patients with Hereditary Angioedema Type I and II: Results from the Icatibant Outcome Survey
    Caballero, Teresa
    Bouillet, Laurence
    Longhurst, Hilary J.
    Aberer, Werner
    Maurer, Marcus
    Zanichelli, Andrea
    Perrin, Amandine
    Andresen, Irmgard
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB253 - AB253
  • [25] Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey
    Longhurst, H. J.
    Bouillet, L.
    Aberer, W.
    Caballero, T.
    Grumach, A. S.
    Botha, J.
    Andresen, I
    Maurer, M.
    [J]. ALLERGY, 2020, 75 : 209 - 209
  • [26] Longitudinal natural history of patients with type I or II hereditary angioedema: data from the icatibant outcome survey
    Maurer, M.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Bygum, A.
    Grumach, A. S.
    Pommie, C.
    Andresen, I
    Longhurst, H. J.
    [J]. ALLERGY, 2017, 72 : 99 - 99
  • [27] CHILDHOOD PRESENTING HEREDITARY ANGIOEDEMA IS DIAGNOSED IN ADULTHOOD BY NON-PEDIATRIC PHYSICIANS: ICATIBANT OUTCOME SURVEY FINDINGS
    Longhurst, H.
    Aberer, W.
    Bouillet, L.
    Caballero, T.
    Bygum, A.
    Grumach, A.
    Perrin, A.
    Andresen, I.
    Zanichelli, A.
    Maurer, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S2 - S2
  • [28] THE ICATIBANT OUTCOME SURVEY: MORE THAN 2200 ICATIBANT-TREATED ATTACKS IN PATIENTS WITH TYPE I OR II HEREDITARY ANGIOEDEMA
    Maurer, Marcus
    Caballero, Teresa
    Aberer, Werner
    Zanichelli, Andrea
    Bouillet, Laurence
    Fabien, Vincent
    Naser, Nadim
    Longhurst, Hilary
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 : 22 - 22
  • [29] The Icatibant Outcome Survey: More Than 1500 Icatibant-Treated Attacks in Patients with Type I or II Hereditary Angioedema
    Maurer, Marcus
    Caballero, Teresa
    Aberer, Werner
    Zanichelli, Andrea
    Bouillet, Laurence
    Fabien, Vincent
    Longhurst, Hilary
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB194 - AB194
  • [30] The icatibant outcome survey: more than 2900 icatibant-treated attacks in patients with type I or II hereditary angioedema
    Maurer, M.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Fabien, V
    Andresen, I
    Longhurst, H. J.
    [J]. ALLERGY, 2016, 71 : 242 - 242